Investment analysts at HC Wainwright lowered their FY2028 earnings estimates for Gossamer Bio in a research note issued on ...

Gossamer Bio ( ($GOSS) ) has released its Q4 earnings. Here is a breakdown of the information Gossamer Bio presented to its investors. Gossamer ...

Stock analysts at HC Wainwright dropped their Q1 2025 earnings estimates for shares of Gossamer Bio in a note issued to investors on Tuesday, March 18th. HC Wainwright analyst P. Trucchio now ...

The Kern County Coroner’s Office has identified a man killed after a crash on Gossamer Grove Boulevard as 22-year-old Luis ...

EDT Gossamer Bio (GOSS) reports Q4 revenue $9.4M, consensus $7.0MLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib fo ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Gossamer Bio (GOSS – Research Report), with a price ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...